Repro Med Systems Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8.9% | +0.4% | +30.0% | +8.6% | +33.5% | +4.4% | -2.8% | +18.8% | +2.2% | +18.0% | +22.2% | |
| – | +1.9% | +1.7% | +38.0% | +0.4% | +27.0% | +11.2% | +5.2% | +28.9% | -5.7% | +4.3% | +26.1% | |
| – | +13.7% | -0.4% | +24.9% | +14.3% | +37.4% | +0.6% | -7.8% | +11.6% | +8.7% | +27.7% | +20.0% | |
| – | -55.7% | +14.6% | -74.4% | +297.2% | +207.1% | +75.1% | +90.8% | +100.4% | +15.9% | -8.4% | -16.6% | |
| – | +24.1% | +30.7% | -0.5% | +17.6% | +7.4% | +23.1% | +48.5% | +15.4% | -1.2% | +6.2% | +8.1% | |
| – | +15.9% | +29.3% | -4.0% | +9.7% | +24.1% | +49.2% | +28.5% | +25.7% | +3.2% | +3.0% | +2.9% | |
| – | +3.0% | -162.3% | – | -21.5% | -49.7% | -314.2% | – | – | – | – | – | |
| – | +566.4% | -44.7% | +3,381.0% | -95.0% | +204,129.3% | -28.0% | -86.8% | -77.2% | – | – | – | |
| – | +6.3% | -168.0% | – | -25.0% | -40.8% | -271.5% | – | – | – | – | – | |
| – | +11.9% | -167.2% | – | -44.9% | -50.4% | -86.5% | -10,221.4% | – | – | -99.9% | +656.7% | |
| – | +3.9% | -168.3% | – | -16.1% | -38.0% | -314.8% | – | – | – | – | – | |
| – | +4.3% | -133.5% | – | +26.4% | +83.0% | -62.9% | -466.3% | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.